Key clinical point: Older black women have higher rates of mortality and worse outcome measures following a major fragility fracture, compared with their white counterparts.
Major finding: Black women had a significantly higher mortality rate after a fracture (19.6% vs. 15.4%) and a significantly higher composite outcome of all three outcome measurements (death, debility, destitution; 24.6% vs. 20.2%), but rates of debility and destitution were similar between groups.
Study details: An analysis of 400,479 white women and 11,563 black women on Medicare with postmenopausal osteoporosis who experienced a major fragility fracture between 2010 and 2016.
Disclosures: Dr. Wright reported receiving grants from Amgen and serving as an expert witness for the law firm Norton Rose Fulbright and Pfizer. Dr. Chen reports receiving grants from Amgen. Dr. Curtis reports receiving grants from and is a consultant for Amgen, Eli Lilly, and Radius. Dr. Saag reports receiving grants from Amgen and is a consultant for Gilead and Radius.
Wright NC et al. ASBMR 2019, Abstract 1125.